Clinical Trials List
Protocol NumberBLI-1005-001 version 3.2
2012-10-29 - 2013-07-31
Phase I
Terminated1
-
Trial Applicant
BioLite, Inc.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- T.P. SU 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
2-32 participants
-
Global
2-32 participants
